These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11180884)

  • 41. Adenomatous hyperplasia of the liver in a patient with congenital hepatic fibrosis.
    Bertheau P; Degott C; Belghiti J; Vilgrain V; Renard P; Benhamou JP; Henin D
    J Hepatol; 1994 Feb; 20(2):213-7. PubMed ID: 8006402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An autopsy case of metastatic foci of hepatocellular carcinoma in adenomatous hyperplasias of the liver.
    Minato H; Nakanuma Y; Kawada N
    Acta Pathol Jpn; 1991 Dec; 41(12):911-5. PubMed ID: 1664640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in the cirrhotic explants of 10 adult French patients.
    Le Bail B; Belleannée G; Bernard PH; Saric J; Balabaud C; Bioulac-Sage P
    Hum Pathol; 1995 Aug; 26(8):897-906. PubMed ID: 7635452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathomorphologic study on early hepatocellular carcinoma (HCC)--a study of cell density in well-differentiated HCC of the early stage].
    Nakashima O; Kiyomatsu K; Iemura A; Edamitsu O; Sugihara S; Kojiro M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1514-9. PubMed ID: 2170717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of well-differentiated hepatocellular carcinoma in large adenomatous hyperplasia after long-term follow-up: a case report.
    Midorikawa Y; Ishikawa T; Kubota K; Mori M; Takayama T; Makuuchi M
    Hepatogastroenterology; 2002; 49(46):1098-101. PubMed ID: 12143212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis.
    Choi BI
    J Korean Med Sci; 1998 Apr; 13(2):103-16. PubMed ID: 9610609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenomatous hyperplasia of the liver as a precancerous lesion.
    Nakanuma Y; Terada T; Ueda K; Terasaki S; Nonomura A; Matsui O
    Liver; 1993 Feb; 13(1):1-9. PubMed ID: 8384281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
    Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY
    Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity.
    Than KW; Okayasu I; Akashi T
    Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A histopathologic study of early hepatocellular carcinoma.
    Kondo Y; Niwa Y; Akikusa B; Takazawa H; Okabayashi A
    Cancer; 1983 Aug; 52(4):687-92. PubMed ID: 6305484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.
    Le Bail B; Bernard PH; Carles J; Balabaud C; Bioulac-Sage P
    J Hepatol; 1997 Nov; 27(5):835-42. PubMed ID: 9382971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemistry and angiography in adenomatous hyperplasia and small hepatocellular carcinomas.
    Yamamoto T; Ikebe T; Mikami S; Shuto T; Hirohashi K; Kinoshita H; Sakurai M
    Pathol Int; 1996 May; 46(5):364-71. PubMed ID: 8809883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia.
    Miskad UA; Yano Y; Nakaji M; Kishi S; Itoh H; Kim SR; Ku Y; Kuroda Y; Hayashi Y
    Pathol Int; 2001 Dec; 51(12):916-22. PubMed ID: 11844063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles.
    Nomura Y; Matsuda Y; Yabuuchi I; Nishioka M; Tarui S
    Radiology; 1993 May; 187(2):353-6. PubMed ID: 8386389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should hepatic dysplastic nodules and regenerative nodules be regarded as premalignant lesions and treated?
    Zhao L; Wong LL; Shi X; Ji J
    Hepatology; 2016 Oct; 64(4):1370. PubMed ID: 26754160
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatocarcinogenesis: imaging-pathologic correlation.
    Park YN; Kim MJ
    Abdom Imaging; 2011 Jun; 36(3):232-43. PubMed ID: 21267560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study.
    Wada K; Kondo F; Kondo Y
    Hepatology; 1988; 8(6):1684-8. PubMed ID: 2847969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis.
    Park YN; Yang CP; Cubukcu O; Thung SN; Theise ND
    Liver; 1997 Dec; 17(6):271-4. PubMed ID: 9455731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.